Search alternatives:
significantly larger » significantly lower (Expand Search), significantly smaller (Expand Search), significantly higher (Expand Search)
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
larger decrease » marked decrease (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
Showing 61 - 80 results of 2,130 for search '(( significantly larger decrease ) OR ( significantly linked decrease ))*', query time: 0.38s Refine Results
  1. 61
    Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022.

    Comparison of Analgesic Consumption by WHO Analgesic Level Between 2023 and 2022. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®).

    Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Multivariate Linear Regression Analysis of Factors Associated with Pain Scores (VAS) in Children Aged 7–12.

    Multivariate Linear Regression Analysis of Factors Associated with Pain Scores (VAS) in Children Aged 7–12. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    Flow chart.

    Flow chart. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    Linear regression.

    Linear regression. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Comparison of Pain Scores (VAS) Between Children Exposed and Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®).

    Comparison of Pain Scores (VAS) Between Children Exposed and Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls.

    ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alterna... by Ananya Datta (19932144)

    Published 2025
    Save to List
    Saved in:
  17. 77
    Bivariate analysis results.

    Bivariate analysis results. by Oejin Shin (20855617)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Regression analysis results with depressive symptoms.

    Regression analysis results with depressive symptoms. by Oejin Shin (20855617)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Regression analysis results with self-rated health.

    Regression analysis results with self-rated health. by Oejin Shin (20855617)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    Sequence analysis results.

    Sequence analysis results. by Oejin Shin (20855617)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: